Medication
Ended Awarded
- Contract number
- 36C24621N0492
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,304
Award facts
- Contract value 100% obligated
- $10,303.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2021, the Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order to Otsuka America Pharmaceutical Inc. for medication supplies with a ceiling value of $10,303.50. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2021, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize any set-aside designation. The place of performance is Potomac, Maryland. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializes in developing and distributing specialty pharmaceuticals to federal healthcare systems, with particular expertise in complex medical conditions.
This delivery order represents a task order against Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle with the VA—specifically an $83.3 million Blanket Purchase Agreement for Jynarque (tolvaptan), a specialized medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The company maintains substantial federal supply schedule contracts totaling approximately $396 million for pharmaceuticals and hematology-related products, enabling efficient procurement of critical pharmaceutical treatments across multiple VA Integrated Service Networks. The delivery order structure allows VA facilities to streamline procurement of these essential medications for veterans nationwide while maintaining firm fixed pricing throughout the contract period.
Quick answers
Who was awarded contract 36C24621N0492?
36C24621N0492 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 13, 2021.
How much is contract 36C24621N0492 worth?
The government has obligated $10,304 on 36C24621N0492.
Is contract 36C24621N0492 an order under another contract?
Yes. 36C24621N0492 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621N0492 competed?
The extent of competition for 36C24621N0492 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award